TNR’s Greg Sargent takes a critical look at the day’s political news and the stories leading NewRepublic.com, and speaks to leading journalists and newsmakers.

President Donald Trump has now set his sights on Somali immigrants. He’s been ranting furiously about them, calling them garbage, and saying he wants them all to get out of our country. And he’s even ...

President Trump’s $250 million addition to the East Wing is his most ambitious makeover of the White House yet. Photo: Kevin Dietsch/Getty Images Warren (D., Mass.), Rep. Dave Min (D., Calif.) and a ...

Providing surgeons feedback and education on their performance significantly improved the quality of bladder cancer operations, finds a new clinical trial led by researchers at UCL, UCLH and the ...

MS NOW host Rachel Maddow revealed on Tuesday she wished she had pressed former Vice President Kamala Harris more during a September interview about the 2024 Democratic nominee’s book. Maddow told ...

EXCLUSIVE: President Donald Trump’s return to the White House has brought a surge in media access following the Biden administration, with hundreds of direct exchanges between a press corps he ...

Brighton's Georginio Rutter has been superb at winning the ball high up the pitch Design: Dan Goldfarb/The Athletic; Photo: Ed Sykes/Getty Images Welcome to the latest edition of The Alternative ...

Wan'Dale Robinson (17) run upfield after making a catch in the second quarter against the Lions on Nov. 23, 2025. Lon Horwedel-Imagn Images Winning leads to an attempt at continuity, the good feelings ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Former White House press secretary Jen Psaki weighed in Thursday on the discourse around Pentagon media access, calling out the new “press corps” for consisting of mostly conservative influencers.

The New York Times has filed a high-stakes lawsuit against the Department of Defense over the Pentagon’s new restrictions on press access. The lawsuit, filed in federal court in Washington, DC ...

The U.S. Food and Drug Administration has approved Pfizer's Padcev (enfortumab vedotin-ejfv), a Nectin-4 directed antibody-drug conjugate, as a perioperative neoadjuvant treatment and postcystectomy ...